{"id":"suraxavir-marboxil","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Suraxavir Marboxil works by inhibiting the activity of the HIV reverse transcriptase enzyme, which is essential for the replication of retroviruses like HIV. This leads to a decrease in viral load and an increase in CD4 cell count.","oneSentence":"Suraxavir Marboxil is a prodrug of suraxavir, a nucleotide reverse transcriptase inhibitor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:37:00.761Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of HIV-1 infection"}]},"trialDetails":[{"nctId":"NCT07236814","phase":"PHASE3","title":"Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2025-11-28","conditions":"Influenza","enrollment":384},{"nctId":"NCT07113392","phase":"PHASE3","title":"A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for Suspension","status":"NOT_YET_RECRUITING","sponsor":"Jiangxi Kvvit Pharmaceutical Co., Ltd.","startDate":"2025-08-01","conditions":"Influenza","enrollment":144}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Suraxavir Marboxil","genericName":"Suraxavir Marboxil","companyName":"Jiangxi Kvvit Pharmaceutical Co., Ltd.","companyId":"jiangxi-kvvit-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Suraxavir Marboxil is a prodrug of suraxavir, a nucleotide reverse transcriptase inhibitor. Used for Treatment of HIV-1 infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}